IP Library Granted Patent US 9,650,671
Granted Patent B2
US 9,650,671 · App. 14/642,307 · Granted May 16, 2017

Sequencing reactions with lithium for pulse width control

Inventors: Andrei Fedorov (San Bruno, CA); John Lyle (Fremont, CA); Keith Bjornson (Fremont, CA); Jeremiah Hanes (Menlo Park, CA)
Assignee: Pacific Biosciences of California, Inc.
C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,650,671
App. No.
14/642,307
Granted
May 16, 2017
Kind
B2
Abstract

Compositions, kits, methods and systems for single molecule nucleotide sequencing comprising producing polymerase reactions having lithium that control the median pulse width for incorporated nucleotides are disclosed. The levels of lithium are used to control pulse width while allowing other sequencing parameters to remain within a desirable range.

Claims (21)

1. A method for performing single molecule sequencing having a pulse width within a desired range comprising:

providing a composition comprising:

a modified recombinant phi-29 type DNA polymerase enzyme having at least 80% sequence similarity to SEQ ID NO: 1, a primer, a template nucleic acid, and a plurality of labeled nucleotide analogs, wherein the composition comprises Li+ at a concentration of from about 0.05 mM to about 40 mM; and

observing the association of the labeled nucleotide analogs with a complex of the polymerase, primer, and template nucleic acid over time to determine a sequence of the template nucleic acid, wherein the concentration of Li+ is selected such that the single molecule sequencing reaction has a median pulse width from about 10 msec to about 400 msec.

2. The method of claim 1 wherein the single molecule sequencing reaction has a median interpulse distance from about 300 msec to about 1.5 s.

3. The method of claim 1 wherein the single molecule sequencing reaction has a median read length greater than 300 bases.

4. The method of claim 1 wherein the concentration of Li+ is from about 0.1 mM to about 4 mM.

5. The method of claim 1 wherein the composition further comprises K+ at a concentration from about 100 mM to about 400 mM.

6. The method of claim 5 wherein the concentration of K+ is from about 150 mM to about 250 mM.

7. The method of claim 1 wherein the polymerase enzyme, primer, and template nucleic acid comprise a polymerase complex that is immobilized on a surface.

8. The method of claim 7 wherein the polymerase complex is immobilized onto the surface by attachment to the surface of the polymerase enzyme or the template nucleic acid.

9. The method of claim 7 wherein the polymerase enzyme complex is immobilized within a confined volume.

10. The method of claim 7 wherein the polymerase complex is immobilized in a zero mode waveguide.

11. The composition of claim 1 wherein the plurality of nucleotide analogs are labeled on the phosphate portion such that the label dissociates upon incorporation into the growing strand.

12. The method of claim 1 wherein the plurality of labeled nucleotide analogs are labeled such that the label is cleaved upon incorporation of the nucleotide analog into the growing strand, the observed pulses corresponding to the time period when the labeled nucleotide analog is associated with the polymerase enzyme complex.

13. The method of claim 12 wherein the polymerase enzyme complex is immobilized onto a substrate.

14. The method of claim 13 wherein the polymerase enzyme complex is immobilized within a confined volume.

15. The method of claim 13 wherein the confined volume comprises a zero mode waveguide.

16. The method of claim 1 wherein the observing is carried out using optical detection.

17. The method of claim 1 wherein the plurality of labeled nucleotide analogs comprise fluorescent or fluorogenic moieties.

18. The method of claim 1 wherein the plurality of labeled nucleotide analogs comprise fluorescent labels.

Continuity (3)
Continuation 13177775 · Jul 7, 2011
Provisional Application 61363591 · Jul 12, 2010
Related Publication 20150203908A1 · Jul 23, 2015